Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

NCT01304303 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.

NCT NCT01304303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01304303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
Lead sponsor
Sun Pharma Advanced Research Company Limited
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2011
Completion date
October 31, 2016
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor in advanced stage